Leadership Team

Dr Hanjing Xie, MD, Associate Prof.

Chief Medical Officer

Dr Hanjing Xie, MD, Associate Prof.

Hanjing joined AMAL Therapeutics in 2023 as Chief Medical Officer.

Hanjing Xie is a medical doctor, associate professor, and senior physician in oncology. She holds a PhD in clinical pharmacology and is triple board certified in clinical oncology, internal medicine, and hematology. She has over 25 years of clinical experience mostly from Karolinska University Hospital. Hanjing has been active in pharmaceutical industry since 2015 and has held several senior leading positions including role of Chief Medical Officer for three Swedish biotech companies most recently.

back to Leadership Team

You are now leaving our website

Using this link will let you leave a website of Amal Therapeutics or to a different domain under the control of Amal Therapeutics. In the event that the linked site is not under the control of Amal Therapeutics but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, Amal Therapeutics shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites.

This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by Amal Therapeutics of the site.

Target URL: